<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04619511</url>
  </required_header>
  <id_info>
    <org_study_id>ESWL&amp;ERCP</org_study_id>
    <nct_id>NCT04619511</nct_id>
  </id_info>
  <brief_title>Risk Factors for Post-ESWL and Post-ERCP Pancreatitis</brief_title>
  <official_title>Risk Factors for Post-ESWL and Post-ERCP Pancreatitis in Patients With Chronic Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to identify risk factors for post-ERCP pancreatitis(PEP) after ESWL, and the&#xD;
      relationship between the occurrence of post-ESWL pancreatitis and PEP.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 31, 2016</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>post endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis</measure>
    <time_frame>up to 1 months</time_frame>
    <description>The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>post pancreatic extracorporeal shock wave lithotripsy (ESWL) pancreatitis</measure>
    <time_frame>up to 1 months</time_frame>
    <description>The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.</description>
  </primary_outcome>
  <enrollment type="Actual">714</enrollment>
  <condition>Chronic Pancreatitis</condition>
  <condition>Risk Factors</condition>
  <condition>ERCP</condition>
  <condition>ESWL</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive CP patients treated with both ESWL and subsequent ERCP during the same&#xD;
        hospitalization between October 2016 and July 2019 were included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with chronic pancreatitis and treated with both ESWL and subsequent&#xD;
             ERCP&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with isolated pancreatic tail stone&#xD;
&#xD;
          -  Patients with suspected or established malignancy&#xD;
&#xD;
          -  Patients with pancreatic ascites&#xD;
&#xD;
          -  Patients attending other interventional clinical trials&#xD;
&#xD;
          -  Patients with non-correctable coagulation disorder&#xD;
&#xD;
          -  Patients with pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Zhuan Liao</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

